Latanoprost punctual plug delivery system is effective in glaucoma treatment

Article

The latanoprost punctual plug delivery system (L-PPDS) is a safe and effective way of administering glaucoma medication, according to ocular company QLT.

The latanoprost punctual plug delivery system (L-PPDS) is a safe and effective way of administering glaucoma medication, according to ocular company QLT.

A phase II trial was conducted on 95 patients and involved the upper and lower puncta for delivery of a daily drug load. The aim was to compare clinical outcomes between latanoprost and daily Xalatan eye drops.

The primary endpoint was the mean change in IOP from baseline at 2 weeks. The secondary endpoints were the mean change in IOP from baseline at 4 weeks and the mean percentage change in IOP from baseline at 2 and 4 weeks.

After 2 weeks of treatment the mean change in IOP was statistically significant at a baseline of -6.2 mmHg. Of the patients studied, 73% presented with an IOP reduction compared to baseline of 5 mmHg or more and 51% demonstrated a reduction of 6 mmHg or more. At 2 weeks the mean change in IOP baseline was statistically significant at -24.3%.

IOP also changed significantly after 4 weeks of L-PPDS. The mean change from baseline was -5.7 mmHg. Out of the patients, 60% showed a reduction of IOP vs baseline of 5 mmHg or higher.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
© 2025 MJH Life Sciences

All rights reserved.